EA201990824A1 - ANTIBODIES THAT CONTACT INTERLEUKIN-2 AND THEIR APPLICATION - Google Patents

ANTIBODIES THAT CONTACT INTERLEUKIN-2 AND THEIR APPLICATION

Info

Publication number
EA201990824A1
EA201990824A1 EA201990824A EA201990824A EA201990824A1 EA 201990824 A1 EA201990824 A1 EA 201990824A1 EA 201990824 A EA201990824 A EA 201990824A EA 201990824 A EA201990824 A EA 201990824A EA 201990824 A1 EA201990824 A1 EA 201990824A1
Authority
EA
Eurasian Patent Office
Prior art keywords
antibodies
interleukin
contact
application
infections
Prior art date
Application number
EA201990824A
Other languages
Russian (ru)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/053880 external-priority patent/WO2018064255A2/en
Publication of EA201990824A1 publication Critical patent/EA201990824A1/en

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Данное раскрытие относится, в целом, к человеческим антителам против интерлейкина-2 человека (ИЛ-2) и способам применения таких антител для модуляции активности ИЛ-2 и применения при лечении состояний, таких как онкологические заболевания, аутоиммунные заболевания или инфекции.This disclosure relates generally to human antibodies against human interleukin-2 (IL-2) and methods for using such antibodies to modulate IL-2 activity and use in the treatment of conditions such as cancer, autoimmune diseases or infections.

EA201990824A 2016-11-11 2017-09-28 ANTIBODIES THAT CONTACT INTERLEUKIN-2 AND THEIR APPLICATION EA201990824A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662421038P 2016-11-11 2016-11-11
PCT/US2017/053880 WO2018064255A2 (en) 2016-09-28 2017-09-28 Antibodies that bind interleukin-2 and uses thereof

Publications (1)

Publication Number Publication Date
EA201990824A1 true EA201990824A1 (en) 2019-10-31

Family

ID=68319028

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201990824A EA201990824A1 (en) 2016-11-11 2017-09-28 ANTIBODIES THAT CONTACT INTERLEUKIN-2 AND THEIR APPLICATION

Country Status (1)

Country Link
EA (1) EA201990824A1 (en)

Similar Documents

Publication Publication Date Title
WO2017134302A3 (en) Targeted therapeutic agents and uses thereof
MX2019012233A (en) Anti-sirp alpha antibodies.
PH12020552229A1 (en) Il-11ra antibodies
EA201890725A1 (en) PHARNESIDE X-RECEPTOR AGONISTS AND THEIR APPLICATION
EA201990043A1 (en) ANTIBACTERIAL CONNECTIONS
EA201892294A1 (en) ANTIBODIES AND COMPOSITIONS AGAINST TIM-3
JOP20200309A1 (en) Il-11 antibodies
EA201991214A1 (en) ANTIBODIES AGAINST PD-1 AND THEIR COMPOSITION
EA201890204A1 (en) ANTIBACTERIAL CONNECTIONS
GEP20217326B (en) Constructs having a sirp-alpha domain or variant thereof
EA201790413A1 (en) ANTIBODIES AGAINST TIGIT
PH12019500643A1 (en) Antibodies that bind interleukin-2 and uses thereof
EA201790273A1 (en) FLAGELLIN COMPOSITIONS AND THEIR APPLICATION
EA201691607A1 (en) MICROORGANOIDS AND METHODS FOR THEIR RECEPTION AND APPLICATION
SA519402159B1 (en) Anti-neuropilin antigen-binding proteins and methods of use thereof
BR112019017403A2 (en) compositions and methods for the treatment of cancer
EA201991005A1 (en) ANTIBODIES AND POLYPEPTIDES AIMED AGAINST CD127
EA201691521A1 (en) ANTIBODIES TO INTERLEUKIN-21
EA201790565A1 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF PREDICATIVE LESIONS OF THE SKIN
PH12019501108A1 (en) Anti-gitr anti-binding protein and methods of use thereof
EA201792571A1 (en) THERAPEUTIC APPLICATION OF L-4-CHLOROKINURENIN
MX2022002635A (en) Angiopoietin-like 4 antibodies and methods of use.
TW201613977A (en) Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use
EA201792560A1 (en) NANOPARTICLES FOR APPLICATION AS A THERAPEUTIC VACCINE
EA202091112A1 (en) SOCRYSTALS, PHARMACEUTICAL COMPOSITIONS BASED ON THEIR BASED AND METHODS OF TREATMENT FOR THEIR APPLICATION